文献速递核素与放射性配体治疗肿瘤 PET/CT

靶向放射性药物治疗联合免疫检查点阻断:从临床前进展到临床

Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic.
PubMed 文献 · J Nucl Med · 2022-09-02

综述指出免疫检查点抑制剂(ICI)对免疫原性差的肿瘤疗效有限,临床前研究显示外照射放疗(EBRT)可与ICI协同使肿瘤消退甚至清除,但EBRT不适合广泛播散病变;靶向放射性药物治疗(TRT)可选择性照射原发灶和转移灶,部分药物(如177Lu-PSMA-617/Pluvicto用于转移性前列腺癌)已获监管批准,TRT联合ICI是新兴研究方向,本文介绍TRT放射生物学基础并综述已联合ICI的新兴及临床转化TRT药物。

要点

  • 临床前研究显示EBRT可与ICI协同促使肿瘤显著消退甚至清除,但EBRT不适合广泛播散病变。
  • TRT选择性照射原发肿瘤和转移部位,部分药物(如177Lu-PSMA-617/Pluvicto用于转移性前列腺癌)已获监管批准。
  • TRT联合ICI是临床前和临床试验中新兴的研究方向。

核心结论

  • TRT联合ICI是临床前和临床试验中新兴的研究方向,旨在进一步改善治疗结局。

研究设计与样本

  • 综述,介绍TRT放射生物学基础,并综述已联合ICI的新兴及临床转化TRT药物。

主要发现

  • 临床前研究显示EBRT可与ICI协同促使肿瘤显著消退甚至清除。
  • EBRT不适合广泛播散性疾病。
  • TRT选择性将辐射递送至原发肿瘤和转移部位。
  • 某些TRT药物(如177Lu-PSMA-617/Pluvicto用于转移性前列腺癌)已获监管批准。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibitors (ICIs) have revolutionized cancer care, but many patients with poorly immunogenic tumors fail to benefit. Preclinical studies have shown that external beam radiotherapy (EBRT) can synergize with ICI to prompt remarkable tumor regression and even eradication. However, EBRT is poorly suited to widely disseminated disease. Targeted radiopharmaceutical therapy (TRT) selectively delivers radiation to both the primary tumor and the metastatic sites, and promising results achieved with this approach have led to regulatory approval of certain agents (e.g., 177Lu-PSMA-617/Pluvicto for metastatic prostate cancer). To further improve therapeutic outcomes, combining TRT and ICI is a burgeoning research area, both preclinically and in clinical trials. Here we introduce basic TRT radiobiology and survey emerging and clinically translated TRT agents that have been combined with ICI.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bellavia MC, Patel RB, Anderson CJ, et al. Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic. J Nucl Med. 2022. PMID: 36215570. doi:10.2967/jnumed.122.264373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。